Jiangsu Nhwa Pharmaceutical Co., Ltd.

This study tested a new drug called NH102 to see if it helps reduce symptoms of major depression. It involved 243 adults with depression who took either NH102 at different doses, an existing drug (duloxetine), or a placebo for 6 weeks. The main goal was to see how well NH102 work…

This early-stage study tested the safety of an experimental oral drug called NH280105, which is being developed for Alzheimer's disease. Researchers gave the drug to 32 healthy adult volunteers to check for side effects and see how the body absorbs and processes it. The study als…

This is a very early study to check the safety of a new drug called NH102, which is being developed to treat depression. It tested multiple dose levels in 40 healthy volunteers to see how their bodies reacted to and processed the drug. The main goal was to find out what side effe…